Drawing for DRIES BETTER

USPTO serial 88499528

DRIES BETTER

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ORTIGA PALMER, RAMONA
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with DRIES BETTER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

MAURY M TEPPER III TEPPER & EYSTER PLLC3724 BENSON DRIVERALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthmaABANDONED—
009Downloadable software in the nature of a mobile application for providing information relating to the treatment of ophthalmic diseases and disordersABANDONED—
035Business administration of patient reimbursement programs; business administration of medication reimbursement programs and services; business administration of pharmacy reimbursement programs and services; doctor's appointment reminder services pertaining to patient visits to doctors, medical centers and specialists, namely, ophthalmologistsABANDONED—
041Educational and training services, namely, conducting classes, seminars and workshops in the field of ophthalmic diseases and disorders; providing online non-downloadable publications in the nature of articles, books and journals in the field of ophthalmic diseases and disorders and the monitoring and management of said diseases and disordersABANDONED—
042Providing temporary use of a non-downloadable web application for processing patient information related to ophthalmologyABANDONED—
044Providing medical information in the field of ophthalmic diseases and disorders; medical services, namely, assisting in the observation, monitoring, adherence and compliance of patients to medical treatmentsABANDONED—
045Organizing and conducting support groups in the field of ophthalmology; Social networking services in the field of ophthalmological diseases and disorders and the monitoring and management of said diseases and disorders provided via a websiteABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 20, 2020MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Feb 20, 2020ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Feb 20, 2020OP.TOPPOSITION TERMINATED NO. 999999—
Feb 20, 2020OP.DOPPOSITION DISMISSED NO. 999999—
Jan 8, 2020OP.IOPPOSITION INSTITUTED NO. 999999—
Sep 26, 2019ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Sep 3, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 3, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 14, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 30, 2019ALIEASSIGNED TO LIE—
Jul 20, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 19, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Jul 19, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 19, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 19, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 18, 2019DOCKASSIGNED TO EXAMINER—
Jul 12, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 6, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance